EP1698349A1 — Method of improving suitability for granulation
Assigned to Takeda Pharmaceutical Co Ltd · Expires 2006-09-06 · 20y expired
What this patent protects
The present invention provides a granulated product having improved granulatability which contains a compound with poor wettability and a surfactant, particularly the granulated product wherein at least about 35% by weight with respect to the total weight of the product does not …
USPTO Abstract
The present invention provides a granulated product having improved granulatability which contains a compound with poor wettability and a surfactant, particularly the granulated product wherein at least about 35% by weight with respect to the total weight of the product does not pass through a 100-mesh sieve, and a method for preparing the granulated product having improved granulatability containing a compound with poor wettability, which comprises adding a surfactant to the compound before or during the granulation, particularly at a weight ratio of about 0.001 to about 2.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.